Gerstein HC - Search Results

1

Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial.

Dagenais GR, Jung H, Bogaty P, Bosch J, Yusuf S, Gerstein HC. Dagenais GR, et al. Among authors: gerstein hc. Diabetes Obes Metab. 2019 Jun;21(6):1502-1505. doi: 10.1111/dom.13674. Epub 2019 Mar 20. Diabetes Obes Metab. 2019. PMID: 30785660 Clinical Trial.

2

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Yusuf S, Lonn E, Bosch J, Gerstein H. Yusuf S, et al. Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45. doi: 10.3109/10641969909061013. Clin Exp Hypertens. 1999. PMID: 10423106 Review.

3

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Anand SS, et al. Lancet. 2000 Jul 22;356(9226):279-84. doi: 10.1016/s0140-6736(00)02502-2. Lancet. 2000. PMID: 11071182

4

Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA. Anand SS, et al. Indian Heart J. 2000 Nov-Dec;52(7 Suppl):S35-43. Indian Heart J. 2000. PMID: 11339439

5

Ramipril and the development of diabetes.

Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators. Yusuf S, et al. JAMA. 2001 Oct 17;286(15):1882-5. doi: 10.1001/jama.286.15.1882. JAMA. 2001. PMID: 11597291 Clinical Trial.

6

Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).

Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Anand SS, et al. Lancet. 2001 Oct 6;358(9288):1147-53. doi: 10.1016/s0140-6736(01)06255-9. Lancet. 2001. PMID: 11597669

7

Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

Gerstein HC. Gerstein HC. Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S82-5. doi: 10.1002/dmrr.285. Diabetes Metab Res Rev. 2002. PMID: 12324991 Review.

8

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Among authors: gerstein hc. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

9

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.

Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K, Malmberg K, McQueen M, Yusuf S; SHARE Investigators. Gerstein HC, et al. Diabetes Care. 2003 Jan;26(1):144-9. doi: 10.2337/diacare.26.1.144. Diabetes Care. 2003. PMID: 12502671

10

Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, Teo KK, Yusuf S. Anand SS, et al. Among authors: gerstein hc. Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290. Diabetes Care. 2003. PMID: 12547851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters